DDW 2018: Choice in patient management
IBD specialists have more treatment options than ever before; yet the optimal use of many agents, old as well as new, remains to be defined. A plenary session… read more.
IBD specialists have more treatment options than ever before; yet the optimal use of many agents, old as well as new, remains to be defined. A plenary session… read more.
One in four people leave their job within a year of returning to work after having a heart attack, according to a study from Denmark in the Journal… read more.
Perianal fistula is a debilitating complication in CD which affects up to 50% of patients in the course of their disease…
The current research and development pipeline of novel biologic therapies and small molecule drugs promises improved efficacy and safety in the treatment of IBD in the near future…. read more.
Cure is not simply about having a few patients cured – it’s about reliably being able to cure a population with a disease, argues Professor S Vincent Rajkumar (Mayo Clinic,… read more.
Author: Bruce Sylvester Exenatide, a drug used to treat diabetes, could have disease-modifying potential in the treatment of Parkinson’s disease, researchers reported on August 3, 2017 in The… read more.
Author: Gary Finnegan A ‘brain training’ game developed by researchers at the University of Cambridge, UK, could help improve the memory of patients in the very earliest stages… read more.
A drug used to prevent epileptic seizures, levetiracetam, shows positive impact on the brain activity of patients with mild Alzheimer’s disease, researches reported on June 23, 2017 in… read more.
Chronic, cancer-related fatigue (CRF) is associated with a sudden- onset, profound lack of energy that is not relieved by rest. It is different from the fatigue experienced by… read more.
Scientists in Sweden are studying whether web-based cognitive behavioural therapy (CBT) is ineffective in some people, potentially making patients worse. The psychologist behind the research say that while… read more.
Researchers who conducted a retrospective analysis of data from over 100,000 surgical cases in one university health system have reported that patients’ pain scores improved when physicians administered… read more.
By Bruce Sylvester Duloxetine (Cymbalta ®), a widely-used treatment for depression and anxiety, appears to reduce joint pain in postmenopausal women being treated for early stage breast cancer,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.